Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Daniele

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Therapeutic Advances in Gastroenterology|June 30, 2023
Brief communication: global temporal trends in the efficacy of clarithromycin-based regimens for the treatment of <i>Helicobacter pylori</i> infectionSteven F Moss, William D Chey, Patrick Daniele, et al.
Future Oncology (London, England)|March 2, 2022
Effectiveness of crizotinib versus entrectinib in <i>ROS1</i>-positive non-small-cell lung cancer using clinical and real-world dataGabriel Tremblay, Michael Groff, Laura Iadeluca, et al.
Journal of Crohn'S & Colitis|February 9, 2023
Filgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from the SELECTION TrialStefan Schreiber, Brian G Feagan, Laurent Peyrin-Biroulet, et al.
Sleep & Breathing = Schlaf & Atmung|June 7, 2022
The rs579459 ABO gene polymorphism and risk of incident cardiovascular events in obstructive sleep apnea: a pilot studyA J Hirsch Allen, Ali Abdul Ghafoor, Yu Liu, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|April 23, 2022
Symptom subtypes and risk of incident cardiovascular and cerebrovascular disease in a clinic-based obstructive sleep apnea cohortA J Hirsch Allen, Rachel Jen, Diego R Mazzotti, et al.
The World Allergy Organization Journal|June 8, 2026
Knowledge of chronic spontaneous urticaria management among Italian general practitioners: Baseline findings from the BRIDGE studyPiergiacomo Calzavara-Pinton, Enrico Iemoli, Pallavi Saraswat, et al.
Plos One|July 30, 2021
Circulating levels of cell adhesion molecules and risk of cardiovascular events in obstructive sleep apneaBernardo U Peres, A J Hirsch Allen, Patrick Daniele, et al.
Journal of the International Association of Providers of AIDS Care|May 12, 2026
Feasibility, Fidelity, and Effectiveness of Administering Long-Acting Cabotegravir + Rilpivirine in Infusion Centers in the United States: Findings From the Phase 4 GLACIER Implementation StudyCassidy A Gutner, Conn Harrington, Gilda Bontempo, et al.
Future Oncology (London, England)|February 2, 2021
Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphomaJatin Shah, Sharon Shacham, Michael Kauffman, et al.
BMC Cancer|September 7, 2021
Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b studyGabriel Tremblay, Patrick Daniele, Janis Breeze, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Therapeutic Advances in Gastroenterology|June 30, 2023
Brief communication: global temporal trends in the efficacy of clarithromycin-based regimens for the treatment of <i>Helicobacter pylori</i> infectionSteven F Moss, William D Chey, Patrick Daniele, et al.
Future Oncology (London, England)|March 2, 2022
Effectiveness of crizotinib versus entrectinib in <i>ROS1</i>-positive non-small-cell lung cancer using clinical and real-world dataGabriel Tremblay, Michael Groff, Laura Iadeluca, et al.
Journal of Crohn'S & Colitis|February 9, 2023
Filgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from the SELECTION TrialStefan Schreiber, Brian G Feagan, Laurent Peyrin-Biroulet, et al.
Sleep & Breathing = Schlaf & Atmung|June 7, 2022
The rs579459 ABO gene polymorphism and risk of incident cardiovascular events in obstructive sleep apnea: a pilot studyA J Hirsch Allen, Ali Abdul Ghafoor, Yu Liu, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|April 23, 2022
Symptom subtypes and risk of incident cardiovascular and cerebrovascular disease in a clinic-based obstructive sleep apnea cohortA J Hirsch Allen, Rachel Jen, Diego R Mazzotti, et al.
The World Allergy Organization Journal|June 8, 2026
Knowledge of chronic spontaneous urticaria management among Italian general practitioners: Baseline findings from the BRIDGE studyPiergiacomo Calzavara-Pinton, Enrico Iemoli, Pallavi Saraswat, et al.
Plos One|July 30, 2021
Circulating levels of cell adhesion molecules and risk of cardiovascular events in obstructive sleep apneaBernardo U Peres, A J Hirsch Allen, Patrick Daniele, et al.
Journal of the International Association of Providers of AIDS Care|May 12, 2026
Feasibility, Fidelity, and Effectiveness of Administering Long-Acting Cabotegravir + Rilpivirine in Infusion Centers in the United States: Findings From the Phase 4 GLACIER Implementation StudyCassidy A Gutner, Conn Harrington, Gilda Bontempo, et al.
Future Oncology (London, England)|February 2, 2021
Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphomaJatin Shah, Sharon Shacham, Michael Kauffman, et al.
BMC Cancer|September 7, 2021
Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b studyGabriel Tremblay, Patrick Daniele, Janis Breeze, et al.
Pageof 2